Dextromethorphan/quinidine sulfate (Zenvia) for Pseudobulbar Affect

Lignende værker

• Evaluating the safety and efficacy of dextromethorphan/quinidine in the treatment of pseudobulbar affect
  af: Schoedel, Kerri A, et al.
  Udgivet: (2014)
• Review of Dextromethorphan 20 mg/Quinidine 10 mg (NUEDEXTA(®)) for Pseudobulbar Affect
  af: Pioro, Erik P.
  Udgivet: (2014)
• Treatment of pseudobulbar affect in a mixed neurodegenerative disorder with compounded quinidine capsules and dextromethorphan cough syrup
  af: Villeneuve, Yannick, et al.
  Udgivet: (2020)
• PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury
  af: Hammond, Flora M., et al.
  Udgivet: (2016)
• An open-label multicenter study to assess the safety of dextromethorphan/quinidine in patients with pseudobulbar affect associated with a range of underlying neurological conditions
  af: Pattee, Gary L., et al.
  Udgivet: (2014)